Results revealed that C1GALT1 high expression in NB tumors constantly predicted better survival outcomes for patients with age >1.5 years (Fig. 1D, p = 0.002, log-rank test), undifferentiated tumor histology (Fig. 1E, p = 0.006, log-rank test), MYCN non-amplified (Fig. 1F, p = 0.014, log-rank test), and advanced stages (Fig. 1G, p = 0.003, log-rank test). Here, C1GALT1 is linked to neoplasm.